Latest Expert Exchange Queries
sitemapHome | Registration | Job Portal for CA's | Expert Exchange | Currency Converter | Post Matrimonial Ads | Post Property Ads
 
 
News shortcuts: From the Courts | News Headlines | VAT (Value Added Tax) | Service Tax | Sales Tax | Placements & Empanelment | Various Acts & Rules | Latest Circulars | New Forms | Forex | Auditing | Direct Tax | Customs and Excise | ICAI | Corporate Law | Markets | Students | General | Indirect Tax | Mergers and Acquisitions | Continuing Prof. Edu. | Budget Extravaganza | Transfer Pricing
 
 
 
 
Popular Search: Central Excise rule to resale the machines to a new company :: TDS :: ICAI offer Get Windows 7,Office 2010 in Rs.799 Taxes :: VAT RATES :: ARTICLES ON INPUT TAX CREDIT IN VAT :: list of goods taxed at 4% :: form 3cd :: VAT Audit :: empanelment :: cpt :: articles on VAT and GST in India :: TAX RATES - GOODS TAXABLE @ 4% :: ACCOUNTING STANDARDS :: due date for vat payment :: ACCOUNTING STANDARD
 
 
« Mergers and Acquisitions »
 The Deal Economy Conference Reveals Upbeat Forecast for Mergers & Acquisitions in 2017
 Mergers and acquisitions almost halve over three months following Brexit vote
 Mergers & acquisitions: a lesson in cyber-security complacency and reputational ruin
 Notable Mergers and Acquisitions 12/5: (CNSL)/(FRP) (CX) (FDML)
 What is Triggering the Wave of Mergers & Acquisitions in the Indian Internet Space?
 Oil and gas mergers and acquisitions are finally making a comeback
  Mergers: Commission approves acquisition of St Jude Medical by Abbott Laboratories, subject to conditions
 Mergers and Acquisitions: What’s Happening in the OFS Industry?
 Mergers: Commission approves acquisition of St Jude Medical by Abbott Laboratories, subject to conditions
 Prediction: These 8 Companies Will Get Bought in 2017
 Third Quarter Results Show Continued Strength in Mergers and Acquisitions

Top executive in Ranbaxy merger and acquisitions team resigns
May, 09th 2011

A top executive of Ranbaxy Laboratories' merger and acquisitions (M&A) team has quit, a development that insiders say reflects a change in strategy of the country's largest drug manufacturer, once known for its aggressive buyouts, to focus on organic growth.

The number two man in the dozen-odd member team, Sandeep Juneja , director (M&A) and Investor Relations, has just put in his papers, several persons familiar with the matter said. Earlier in November last year, Anil Khandelwal, head and director (M&A), had also left the organisation.

"The M&A activity in the firm has considerably slowed down and that explains the exits," a person familiar with the development said. The Ranbaxy spokesman said: "The company has significant depth of management and is adequately staffed to take care of any M&A opportunity that may arise."

Ranbaxy was most aggressive in buying firms during 2006 and 2007 under former promoters Malvinder and Shivinder Singh. In 2006 alone, it bought five companies overseas, Italy's AllenSpA, Terapia of Romania, Ethimed of Belgium, Spain's Mundogen and Be-Tabs Pharmaceuticals of South Africa.

Ranbaxy also picked up significant minority equity stake in several niche Indian drug manufacturers such as Zenotech Laboratories , Orchid Chemicals, Jupiter Bioscience and Krebs Biochemicals to foray into specialised therapeutic segments. Analysts say after Japan's Daiichi Sankyo took over the firm, it was but natural to expect the overseas acquisition drive to moderate. But Ranbaxy also scaled back its domestic deals.

In the last three years, the Gurgaon-based company bought just one firm, a small Bangalore-based biotech company Biovel Lifesciences for around Rs 50 crore.

Two persons close to the development said the company remains open to acquisitions but valuations of pharma firms are unreasonably high. "Ranbaxy has presence in all the key markets and therapeutic areas and it does not make sense to buy a firm for the sake of growing the top line," one of them said.

The second executive said all significant deals in India in the recent past involved an international buyer and other local drugmakers have not been too active in buying.

 
 
Home | About Us | Terms and Conditions | Contact Us
Copyright 2016 CAinINDIA All Right Reserved.
Designed and Developed by Binarysoft Technologies Pvt. Ltd.
Internet Marketing Website Marketing Internet Promotion Internet Marketing India Website Marketing India Internet Promotion India Internet Marketing Consultancy Website Marketing Consulta

Transfer Pricing | International Taxation | Business Consulting | Corporate Compliance and Consulting | Assurance and Risk Advisory | Indirect Taxes | Direct Taxes | Transaction Advisory | Regular Compliance and Reporting | Tax Assessments | International Taxation Advisory | Capital Structuring | Withholding tax advisory | Expatriate Tax Reporting | Litigation | Badges | Club Badges | Seals | Military Insignias | Emblems | Family Crest | Software Development India | Software Development Company | SEO Company | Web Application Development | MLM Software | MLM Solutions